{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:28:59Z","timestamp":1791563339251,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,23]]},"DOI":"10.7759\/cureus.27167","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T06:15:00Z","timestamp":1658556900000},"source":"Crossref","is-referenced-by-count":27,"title":["Anemia and Heart Failure: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Shiza W","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejaswini","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassar","family":"Patni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahejabeen","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aselah","family":"Lamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Kishore","family":"Anne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin EJ","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, et al.. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019, 139:e56-e528. 10.1161\/CIR.0000000000000659","journal-title":"Circulation"},{"key":"ref2","unstructured":"Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. (2011). https.\/\/www.who.int\/publications\/i\/item\/WHO-NMH-NHD-MNM-11.1."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20130126","article-title":"Anemia, heart failure and evidence-based clinical management","volume":"101","author":"Pereira CA","year":"2013","unstructured":"Pereira CA, Roscani MG, Zanati SG, Matsubara BB. Anemia, heart failure and evidence-based clinical management. Arq Bras Cardiol. 2013, 101:87-92. 10.5935\/abc.20130126","journal-title":"Arq Bras Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients a systematic review and meta-analysis","volume":"52","author":"Groenveld HF","year":"2008","unstructured":"Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol. 2008, 52:818-27. 10.1016\/j.jacc.2008.04.061","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14744\/AnatolJCardiol.2018.08634","article-title":"Anemia in heart failure - from guidelines to controversies and challenges","volume":"20","author":"S\u00eerbu O","year":"2018","unstructured":"S\u00eerbu O, Floria M, Dascalita P, Stoica A, Adascalitei P, Sorodoc V, Sorodoc L. Anemia in heart failure - from guidelines to controversies and challenges. Anatol J Cardiol. 2018, 20:52-9. 10.14744\/AnatolJCardiol.2018.08634","journal-title":"Anatol J Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss G","year":"2005","unstructured":"Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005, 352:1011-23. 10.1056\/NEJMra041809","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.583666","article-title":"Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options","volume":"113","author":"Tang YD","year":"2006","unstructured":"Tang YD, Katz SD. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation. 2006, 113:2454-61. 10.1161\/CIRCULATIONAHA.105.583666","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand IS","year":"2018","unstructured":"Anand IS, Gupta P. Anemia and iron deficiency in heart failure: current concepts and emerging therapies. Circulation. 2018, 138:80-98. 10.1161\/CIRCULATIONAHA.118.030099","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip IT","year":"2013","unstructured":"Klip IT, Comin-Colet J, Voors AA, et al.. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013, 165:575-582.e3. 10.1016\/j.ahj.2013.01.017","journal-title":"Am Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2015.12.023","article-title":"Absolute and functional iron deficiency is a common finding in patients with heart failure and after heart transplantation","volume":"48","author":"Przybylowski P","year":"2016","unstructured":"Przybylowski P, Wasilewski G, Golabek K, Bachorzewska-Gajewska H, Dobrzycki S, Koc-Zorawska E, Malyszko J. Absolute and functional iron deficiency is a common finding in patients with heart failure and after heart transplantation. Transplant Proc. 2016, 48:173-6. 10.1016\/j.transproceed.2015.12.023","journal-title":"Transplant Proc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1042\/CS20040278","article-title":"Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration","volume":"109","author":"Dong F","year":"2005","unstructured":"Dong F, Zhang X, Culver B, Chew HG Jr, Kelley RO, Ren J. Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. Clin Sci (Lond). 2005, 109:277-86. 10.1042\/CS20040278","journal-title":"Clin Sci (Lond)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.640","article-title":"Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis","volume":"19","author":"Melenovsky V","year":"2017","unstructured":"Melenovsky V, Petrak J, Mracek T, et al.. Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. Eur J Heart Fail. 2017, 19:522-30. 10.1002\/ejhf.640","journal-title":"Eur J Heart Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi388","article-title":"Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure","volume":"26","author":"Opasich C","year":"2005","unstructured":"Opasich C, Cazzola M, Scelsi L, et al.. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J. 2005, 26:2232-7. 10.1093\/eurheartj\/ehi388","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2014.04.005","article-title":"Anemia of inflammation","volume":"28","author":"Nemeth E","year":"2014","unstructured":"Nemeth E, Ganz T. Anemia of inflammation. Hematol Oncol Clin North Am. 2014, 28:671-81, vi. 10.1016\/j.hoc.2014.04.005","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref15","article-title":"Cytokines and heart failure","volume":"1","author":"Paulus WJ","year":"2000","unstructured":"Paulus WJ. Cytokines and heart failure. Heart Fail Monit. 2000, 1:50-6.","journal-title":"Heart Fail Monit"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(96)00268-9","article-title":"Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension","volume":"28","author":"Testa M","year":"1996","unstructured":"Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman JW, LeJemtel TH. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol. 1996, 28:964-71. 10.1016\/s0735-1097(96)00268-9","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-010-9180-8","article-title":"TNF\u03b1 in myocardial ischemia\/reperfusion, remodeling and heart failure","volume":"16","author":"Kleinbongard P","year":"2011","unstructured":"Kleinbongard P, Schulz R, Heusch G. TNF\u03b1 in myocardial ischemia\/reperfusion, remodeling and heart failure. Heart Fail Rev. 2011, 16:49-69. 10.1007\/s10741-010-9180-8","journal-title":"Heart Fail Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.91.5.1520","article-title":"Hypoxic stress induces cardiac myocyte-derived interleukin-6","volume":"91","author":"Yamauchi-Takihara K","year":"1995","unstructured":"Yamauchi-Takihara K, Ihara Y, Ogata A, Yoshizaki K, Azuma J, Kishimoto T. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation. 1995, 91:1520-4. 10.1161\/01.cir.91.5.1520","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.81.5.664","article-title":"Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor\/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload","volume":"81","author":"Shioi T","year":"1997","unstructured":"Shioi T, Matsumori A, Kihara Y, et al.. Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor\/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ Res. 1997, 81:664-71. 10.1161\/01.res.81.5.664","journal-title":"Circ Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7013.s5-003","article-title":"The cardiomyocyte as a source of cytokines in cardiac injury","volume":"2012","author":"Aoyagi T","year":"2011","unstructured":"Aoyagi T, Matsui T. The cardiomyocyte as a source of cytokines in cardiac injury. J Cell Sci Ther. 2011, 2012:10.4172\/2157-7013.s5-003","journal-title":"J Cell Sci Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe0910313","article-title":"Anemia and iron deficiency--new therapeutic targets in heart failure?","volume":"361","author":"Dec GW","year":"2009","unstructured":"Dec GW. Anemia and iron deficiency--new therapeutic targets in heart failure?. N Engl J Med. 2009, 361:2475-7. 10.1056\/NEJMe0910313","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S27105","article-title":"Anemia associated with chronic heart failure: current concepts","volume":"8","author":"Shah R","year":"2013","unstructured":"Shah R, Agarwal AK. Anemia associated with chronic heart failure: current concepts. Clin Interv Aging. 2013, 8:111-22. 10.2147\/CIA.S27105","journal-title":"Clin Interv Aging"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000356193","article-title":"Physiology and pharmacology of erythropoietin","volume":"40","author":"Jelkmann W","year":"2013","unstructured":"Jelkmann W. Physiology and pharmacology of erythropoietin. Transfus Med Hemother. 2013, 40:302-9. 10.1159\/000356193","journal-title":"Transfus Med Hemother"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.03.052","article-title":"Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure","volume":"44","author":"van der Meer P","year":"2004","unstructured":"van der Meer P, Voors AA, Lipsic E, Smilde TD, van Gilst WH, van Veldhuisen DJ. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. J Am Coll Cardiol. 2004, 44:63-7. 10.1016\/j.jacc.2004.03.052","journal-title":"J Am Coll Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-5299.2007.06662.x","article-title":"Erythropoietin in chronic heart failure","volume":"13","author":"Belonje AM","year":"2007","unstructured":"Belonje AM, Voors AA, van Gilst WH, van Veldhuisen DJ. Erythropoietin in chronic heart failure. Congest Heart Fail. 2007, 13:289-92. 10.1111\/j.1527-5299.2007.06662.x","journal-title":"Congest Heart Fail"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2005.01525.x","article-title":"Regulation of erythropoietin production","volume":"35 Suppl 3","author":"Eckardt KU","year":"2005","unstructured":"Eckardt KU, Kurtz A. Regulation of erythropoietin production. Eur J Clin Invest. 2005, 35 Suppl 3:13-9. 10.1111\/j.1365-2362.2005.01525.x","journal-title":"Eur J Clin Invest"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn399","article-title":"Erythropoietin, haemoglobin, heart failure, and mortality","volume":"29","author":"Diskin CJ","year":"2008","unstructured":"Diskin CJ. Erythropoietin, haemoglobin, heart failure, and mortality. Eur Heart J. 2008, 29:2695; author reply 2695-6. 10.1093\/eurheartj\/ehn399","journal-title":"Eur Heart J"},{"key":"ref28","article-title":"Physiology, Renin Angiotensin System","author":"Fountain JH","year":"2022","unstructured":"Fountain JH, Lappin SL. Physiology, Renin Angiotensin System. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2016-134045","article-title":"The renin-angiotensin-aldosterone system in heart failure for the non-specialist: the past, the present and the future","volume":"93","author":"Orsborne C","year":"2017","unstructured":"Orsborne C, Chaggar PS, Shaw SM, Williams SG. The renin-angiotensin-aldosterone system in heart failure for the non-specialist: the past, the present and the future. Postgrad Med J. 2017, 93:29-37. 10.1136\/postgradmedj-2016-134045","journal-title":"Postgrad Med J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3317\/jraas.2004.024","article-title":"The role of the renin-angiotensin-aldosterone system in heart failure","volume":"5 Suppl 1","author":"Unger T","year":"2004","unstructured":"Unger T, Li J. The role of the renin-angiotensin-aldosterone system in heart failure. J Renin Angiotensin Aldosterone Syst. 2004, 5 Suppl 1:S7-10. 10.3317\/jraas.2004.024","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.549121","article-title":"Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure","volume":"112","author":"van der Meer P","year":"2005","unstructured":"van der Meer P, Lipsic E, Westenbrink BD, et al.. Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation. 2005, 112:1743-7. 10.1161\/CIRCULATIONAHA.105.549121","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl419","article-title":"Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well","volume":"28","author":"Westenbrink BD","year":"2007","unstructured":"Westenbrink BD, Visser FW, Voors AA, et al.. Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well. Eur Heart J. 2007, 28:166-71. 10.1093\/eurheartj\/ehl419","journal-title":"Eur Heart J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18504","article-title":"Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network","volume":"8","author":"Lin Y","year":"2017","unstructured":"Lin Y, He S, Feng R, et al.. Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network. Oncotarget. 2017, 8:57003-11. 10.18632\/oncotarget.18504","journal-title":"Oncotarget"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.06.064","article-title":"Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure","volume":"100","author":"Schou M","year":"2007","unstructured":"Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure. Am J Cardiol. 2007, 100:1571-6. 10.1016\/j.amjcard.2007.06.064","journal-title":"Am J Cardiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl012","article-title":"The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET","volume":"27","author":"Komajda M","year":"2006","unstructured":"Komajda M, Anker SD, Charlesworth A, et al.. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J. 2006, 27:1440-6. 10.1093\/eurheartj\/ehl012","journal-title":"Eur Heart J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.19.2237","article-title":"Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project","volume":"165","author":"Kosiborod M","year":"2005","unstructured":"Kosiborod M, Curtis JP, Wang Y, et al.. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. Arch Intern Med. 2005, 165:2237-44. 10.1001\/archinte.165.19.2237","journal-title":"Arch Intern Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000134279.79571.73","article-title":"Anemia and its relationship to clinical outcome in heart failure","volume":"110","author":"Anand I","year":"2004","unstructured":"Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, Burton PB. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004, 110:149-54. 10.1161\/01.CIR.0000134279.79571.73","journal-title":"Circulation"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000052622.51963.fc","article-title":"Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure","volume":"107","author":"Ezekowitz JA","year":"2003","unstructured":"Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 2003, 107:223-5. 10.1161\/01.cir.0000052622.51963.fc","journal-title":"Circulation"},{"key":"ref39","unstructured":"International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). (2021). Accessed. June 7, 2022: https:\/\/www.cdc.gov\/nchs\/icd\/icd9cm.htm."},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(02)01854-5","article-title":"Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure","volume":"39","author":"Horwich TB","year":"2002","unstructured":"Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002, 39:1780-6. 10.1016\/s0735-1097(02)01854-5","journal-title":"J Am Coll Cardiol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski P","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al.. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016, 18:891-975. 10.1002\/ejhf.592","journal-title":"Eur J Heart Fail"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs224","article-title":"Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives","volume":"34","author":"Jankowska EA","year":"2013","unstructured":"Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J. 2013, 34:816-29. 10.1093\/eurheartj\/ehs224","journal-title":"Eur Heart J"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.820","article-title":"Iron deficiency and red cell indices in patients with heart failure","volume":"20","author":"Tkaczyszyn M","year":"2018","unstructured":"Tkaczyszyn M, Com\u00edn-Colet J, Voors AA, et al.. Iron deficiency and red cell indices in patients with heart failure. Eur J Heart Fail. 2018, 20:114-22. 10.1002\/ejhf.820","journal-title":"Eur J Heart Fail"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2014.07.049","article-title":"Diagnosis and treatment of iron deficiency in patients with heart failure: expert position paper from French cardiologists","volume":"107","author":"Cohen-Solal A","year":"2014","unstructured":"Cohen-Solal A, Leclercq C, Mebazaa A, De Groote P, Damy T, Isnard R, Galinier M. Diagnosis and treatment of iron deficiency in patients with heart failure: expert position paper from French cardiologists. Arch Cardiovasc Dis. 2014, 107:563-71. 10.1016\/j.acvd.2014.07.049","journal-title":"Arch Cardiovasc Dis"},{"key":"ref45","article-title":"Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy","volume":"84","year":"1996","unstructured":"Practice guidelines for blood component therapy. a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology. 1996, 84:732-47.","journal-title":"Anesthesiology"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis GD","year":"2017","unstructured":"Lewis GD, Malhotra R, Hernandez AF, et al.. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. JAMA. 2017, 317:1958-66. 10.1001\/jama.2017.5427","journal-title":"JAMA"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.04.181","article-title":"IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia","volume":"168","author":"Beck-da-Silva L","year":"2013","unstructured":"Beck-da-Silva L, Piardi D, Soder S, et al.. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. Int J Cardiol. 2013, 168:3439-42. 10.1016\/j.ijcard.2013.04.181","journal-title":"Int J Cardiol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli JE","year":"2007","unstructured":"Toblli JE, Lombra\u00f1a A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol. 2007, 50:1657-65. 10.1016\/j.jacc.2007.07.029","journal-title":"J Am Coll Cardiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.473","article-title":"Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials","volume":"18","author":"Jankowska EA","year":"2016","unstructured":"Jankowska EA, Tkaczyszyn M, Suchocki T, et al.. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. Eur J Heart Fail. 2016, 18:786-95. 10.1002\/ejhf.473","journal-title":"Eur J Heart Fail"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"136","author":"Yancy CW","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al.. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017, 136:e137-61. 10.1161\/CIR.0000000000000509","journal-title":"Circulation"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00215.x","article-title":"Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV\/AIDS, and chronic kidney disease","volume":"11","author":"Kimel M","year":"2008","unstructured":"Kimel M, Leidy NK, Mannix S, Dixon J. Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV\/AIDS, and chronic kidney disease. Value Health. 2008, 11:57-75. 10.1111\/j.1524-4733.2007.00215.x","journal-title":"Value Health"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.04.187","article-title":"The effects of erythropoiesis stimulating therapy for anemia in chronic heart failure: a meta-analysis of randomized clinical trials","volume":"218","author":"Kang J","year":"2016","unstructured":"Kang J, Park J, Lee JM, Park JJ, Choi DJ. The effects of erythropoiesis stimulating therapy for anemia in chronic heart failure: a meta-analysis of randomized clinical trials. Int J Cardiol. 2016, 218:12-22. 10.1016\/j.ijcard.2016.04.187","journal-title":"Int J Cardiol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.5114\/aic.2016.61647","article-title":"Effects of erythropoiesis-stimulating agents on heart failure patients with anemia: a meta-analysis","volume":"12","author":"Zhang H","year":"2016","unstructured":"Zhang H, Zhang P, Zhang Y, Yan J, Dong P, Wang Y, Niu X. Effects of erythropoiesis-stimulating agents on heart failure patients with anemia: a meta-analysis. Postepy Kardiol Interwencyjnej. 2016, 12:247-53. 10.5114\/aic.2016.61647","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg K","year":"2013","unstructured":"Swedberg K, Young JB, Anand IS, et al.. Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med. 2013, 368:1210-9. 10.1056\/NEJMoa1214865","journal-title":"N Engl J Med"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.698514","article-title":"Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia","volume":"117","author":"Ghali JK","year":"2008","unstructured":"Ghali JK, Anand IS, Abraham WT, et al.. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation. 2008, 117:526-35. 10.1161\/CIRCULATIONAHA.107.698514","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/100886-anemia-and-heart-failure-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:36:27Z","timestamp":1707489387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/100886-anemia-and-heart-failure-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":55,"URL":"https:\/\/doi.org\/10.7759\/cureus.27167","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,23]]}}}